Cargando…
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such a...
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220575/ https://www.ncbi.nlm.nih.gov/pubmed/32404975 http://dx.doi.org/10.1038/s41409-020-0919-0 |
| _version_ | 1783533193860743168 |
|---|---|
| author | Ljungman, Per Mikulska, Malgorzata de la Camara, Rafael Basak, Grzegorz W. Chabannon, Christian Corbacioglu, Selim Duarte, Rafael Dolstra, Harry Lankester, Arjan C. Mohty, Mohamad Montoto, Silvia Murray, John Peffault de Latour, Régis Snowden, John A. Yakoub-Agha, Ibrahim Verhoeven, Bregje Kröger, Nicolaus Styczynski, Jan |
| author_facet | Ljungman, Per Mikulska, Malgorzata de la Camara, Rafael Basak, Grzegorz W. Chabannon, Christian Corbacioglu, Selim Duarte, Rafael Dolstra, Harry Lankester, Arjan C. Mohty, Mohamad Montoto, Silvia Murray, John Peffault de Latour, Régis Snowden, John A. Yakoub-Agha, Ibrahim Verhoeven, Bregje Kröger, Nicolaus Styczynski, Jan |
| author_sort | Ljungman, Per |
| collection | PubMed |
| description | The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such as with CAR T cells. Risk factors for severe disease include age and predisposing conditions such as cancer. The true impact on stem cell transplant and CAR T-cell recipients in unknown. The European Society for Blood and Marrow Transplantation (EBMT) has therefore developed recommendations for transplant programs and physicians caring for these patients. These guidelines were developed by experts from the Infectious Diseases Working Party and have been endorsed by EBMT’s scientific council and board. This work intends to provide guidelines for transplant centers, management of transplant candidates and recipients, and donor issues until the COVID-19 pandemic has passed. |
| format | Online Article Text |
| id | pubmed-7220575 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72205752020-05-14 The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy Ljungman, Per Mikulska, Malgorzata de la Camara, Rafael Basak, Grzegorz W. Chabannon, Christian Corbacioglu, Selim Duarte, Rafael Dolstra, Harry Lankester, Arjan C. Mohty, Mohamad Montoto, Silvia Murray, John Peffault de Latour, Régis Snowden, John A. Yakoub-Agha, Ibrahim Verhoeven, Bregje Kröger, Nicolaus Styczynski, Jan Bone Marrow Transplant Perspective The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such as with CAR T cells. Risk factors for severe disease include age and predisposing conditions such as cancer. The true impact on stem cell transplant and CAR T-cell recipients in unknown. The European Society for Blood and Marrow Transplantation (EBMT) has therefore developed recommendations for transplant programs and physicians caring for these patients. These guidelines were developed by experts from the Infectious Diseases Working Party and have been endorsed by EBMT’s scientific council and board. This work intends to provide guidelines for transplant centers, management of transplant candidates and recipients, and donor issues until the COVID-19 pandemic has passed. Nature Publishing Group UK 2020-05-13 2020 /pmc/articles/PMC7220575/ /pubmed/32404975 http://dx.doi.org/10.1038/s41409-020-0919-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Perspective Ljungman, Per Mikulska, Malgorzata de la Camara, Rafael Basak, Grzegorz W. Chabannon, Christian Corbacioglu, Selim Duarte, Rafael Dolstra, Harry Lankester, Arjan C. Mohty, Mohamad Montoto, Silvia Murray, John Peffault de Latour, Régis Snowden, John A. Yakoub-Agha, Ibrahim Verhoeven, Bregje Kröger, Nicolaus Styczynski, Jan The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy |
| title | The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy |
| title_full | The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy |
| title_fullStr | The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy |
| title_full_unstemmed | The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy |
| title_short | The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy |
| title_sort | challenge of covid-19 and hematopoietic cell transplantation; ebmt recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing car t-cell therapy |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220575/ https://www.ncbi.nlm.nih.gov/pubmed/32404975 http://dx.doi.org/10.1038/s41409-020-0919-0 |
| work_keys_str_mv | AT ljungmanper thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT mikulskamalgorzata thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT delacamararafael thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT basakgrzegorzw thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT chabannonchristian thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT corbaciogluselim thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT duarterafael thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT dolstraharry thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT lankesterarjanc thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT mohtymohamad thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT montotosilvia thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT murrayjohn thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT peffaultdelatourregis thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT snowdenjohna thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT yakoubaghaibrahim thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT verhoevenbregje thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT krogernicolaus thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT styczynskijan thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT thechallengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT ljungmanper challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT mikulskamalgorzata challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT delacamararafael challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT basakgrzegorzw challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT chabannonchristian challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT corbaciogluselim challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT duarterafael challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT dolstraharry challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT lankesterarjanc challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT mohtymohamad challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT montotosilvia challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT murrayjohn challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT peffaultdelatourregis challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT snowdenjohna challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT yakoubaghaibrahim challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT verhoevenbregje challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT krogernicolaus challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT styczynskijan challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy AT challengeofcovid19andhematopoieticcelltransplantationebmtrecommendationsformanagementofhematopoieticcelltransplantrecipientstheirdonorsandpatientsundergoingcartcelltherapy |